Published in Eur J Neurol on October 01, 2015
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. Eur J Immunol (2016) 0.75
1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Immunology (2017) 0.75
Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches. Biomed Res Int (2016) 0.75
N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling. J Neuroinflammation (2016) 0.75
Laquinimod in the treatment of multiple sclerosis: a review of the data so far. Drug Des Devel Ther (2016) 0.75
Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia. Neurochem Res (2017) 0.75
Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota. Front Immunol (2017) 0.75
Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs. J Syst Integr Neurosci (2017) 0.75
An overview of pregnancy-related issues in patients with multiple sclerosis. Eur J Neurol (2015) 0.83
'Hidden' factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol (2015) 0.82
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations. Eur J Neurol (2015) 0.78
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice. Eur J Neurol (2015) 0.75